Introduction: Specific biomarkers for predicting response and risk of recurrence after surgery for enteropancreatic neuroendocrine tumours (EP-NETs) are still lacking.
Aim(s): Aim of this prospective study was to evaluate if blood measurement of neuroendocrine gene transcripts (NETest) correlates with the efficacy of surgical resection for EP-NET.
Materials and methods: Between April and November 2017, all patients affected by EP-NETs scheduled for surgery were enrolled in this prospective study (NCT 03012789). Whole blood samples for NETest and plasma for Chromogranin A (CgA) were collected preoperatively and on postoperative day 1 (POD1) and 5 (POD5). Transcripts were blinding measured by real-time quantitative reverse transcription PCR (qRT-PCR) and multianalyte algorithmic analysis (NETest); CgA by enzyme-linked immunosorbent assay (ELISA).
Conference: 15th Annual ENETS conference 2018 (2018)
Presenting Author: Francesca Muffatti
To read results and conclusion, please login ...
Further abstracts you may be interested in